Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Main Capital in connection with the sale of Alfa eCare
Mandate

Vinge advises Main Capital in connection with the sale of Alfa eCare

July 10, 2025 M&A Banking and Finance Commercial Agreements IT, Telecommunications and Outsourcing Employment and Benefits Intellectual Property

Vinge has advised Main Capital in connection with the sale of Alfa eCare Holding AB and its subsidiaries (“Alfa eCare”) to SDB Groep B.V. (“SDB”)

Alfa eCare is a leading provider of digital healthcare, welfare and childcare software in the Nordics. Headquartered in Sweden with offices in Finland and Denmark, Alfa eCare employs approximately 120 people and serves over 1,300 clients across public and private sectors. SDB is a market leading healthcare and childcare software player in the Netherlands, serving elderly care, disabled care, mental health, rehabilitation, youth care, childcare, and independent treatment centers (ITCs).

SDB and Alfa eCare are joining forces to create a leading position in the European Healthcare and Welfare market. The combination establishes a unique player, which offers a comprehensive modular suite of solutions for primary and secondary processes of healthcare and welfare organizations across Europe.

Vinge’s team consisted primarily of Filip Öhrner, Jonatan Stentorp, Ian Linde (M&A), Felix Möller, Sofia Haggren (Banking & Finance), Martin Boström, Siri Blomberg (Commercial Agreements and IT & GDPR), Alice Göransson, Louisa Fagarasan (Employment), Felizia Wiker (IP), Caroline Löv och Jasmina Skandrani (Transaction Support).

Related

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge advises Studentbostäder i Norden AB (publ) in connection with its issuance of bonds in an amount of SEK 500 million and its early redemption of outstanding bonds

 Vinge has advised Studentbostäder i Norden AB (publ) in connection with its issuance of senior unsecured bonds in an amount of SEK 500 million (within a framework of SEK 750 million) and in parallel with the company's voluntary early redemption of previously issued bonds.
March 12, 2026